Price T Rowe Associates Inc. MD Cuts Holdings in Xometry, Inc. (NASDAQ:XMTR)

Price T Rowe Associates Inc. MD lessened its position in shares of Xometry, Inc. (NASDAQ:XMTR - Free Report) by 57.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 48,501 shares of the company's stock after selling 66,750 shares during the period. Price T Rowe Associates Inc. MD owned approximately 0.10% of Xometry worth $2,070,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Harvest Investment Services LLC acquired a new stake in Xometry during the 4th quarter worth approximately $504,000. Hsbc Holdings PLC purchased a new stake in Xometry during the fourth quarter worth approximately $234,000. OneDigital Investment Advisors LLC acquired a new stake in shares of Xometry in the fourth quarter worth $2,673,000. MetLife Investment Management LLC raised its stake in shares of Xometry by 5.0% in the 4th quarter. MetLife Investment Management LLC now owns 26,086 shares of the company's stock valued at $1,113,000 after acquiring an additional 1,241 shares during the period. Finally, Dimensional Fund Advisors LP lifted its holdings in shares of Xometry by 5.8% during the 4th quarter. Dimensional Fund Advisors LP now owns 528,194 shares of the company's stock valued at $22,537,000 after acquiring an additional 28,892 shares in the last quarter. 97.31% of the stock is currently owned by institutional investors and hedge funds.

Xometry Trading Down 2.2 %

NASDAQ XMTR opened at $29.95 on Thursday. The company has a market capitalization of $1.51 billion, a price-to-earnings ratio of -28.52 and a beta of 0.71. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.59 and a quick ratio of 4.55. Xometry, Inc. has a 12 month low of $11.08 and a 12 month high of $45.33. The company's fifty day moving average price is $24.39 and its two-hundred day moving average price is $29.99.

Insider Transactions at Xometry

In other Xometry news, CEO Randolph Altschuler sold 27,566 shares of the stock in a transaction on Friday, February 28th. The shares were sold at an average price of $26.60, for a total transaction of $733,255.60. Following the sale, the chief executive officer now directly owns 256,570 shares of the company's stock, valued at approximately $6,824,762. This represents a 9.70 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Peter Goguen sold 3,000 shares of Xometry stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $35.57, for a total transaction of $106,710.00. Following the completion of the transaction, the chief operating officer now directly owns 161,993 shares of the company's stock, valued at $5,762,091.01. This trade represents a 1.82 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 78,256 shares of company stock valued at $2,012,889. Insiders own 16.79% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on XMTR. Citigroup lowered their price target on Xometry from $46.00 to $39.00 and set a "buy" rating for the company in a report on Thursday, February 27th. Royal Bank of Canada raised their target price on Xometry from $32.00 to $36.00 and gave the company a "sector perform" rating in a report on Wednesday. UBS Group upped their price target on Xometry from $33.00 to $35.00 and gave the stock a "neutral" rating in a report on Wednesday. JMP Securities reiterated a "market outperform" rating and set a $42.00 price objective on shares of Xometry in a research note on Monday, February 10th. Finally, JPMorgan Chase & Co. lowered their price target on shares of Xometry from $45.00 to $30.00 and set an "overweight" rating for the company in a report on Tuesday, April 22nd. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, Xometry has a consensus rating of "Moderate Buy" and a consensus price target of $34.33.

Xometry Profile

Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.

Want to see what other hedge funds are holding XMTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xometry, Inc. (NASDAQ:XMTR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.